Waldencast plc (NASDAQ:WALD - Get Free Report)'s share price dropped 3.9% during trading on Thursday . The company traded as low as $5.39 and last traded at $5.39. Approximately 498 shares were traded during mid-day trading, a decline of 99% from the average daily volume of 67,966 shares. The stock had previously closed at $5.61.
Analyst Upgrades and Downgrades
Separately, Telsey Advisory Group reduced their target price on Waldencast from $12.00 to $10.00 and set an "outperform" rating for the company in a report on Friday, March 22nd.
Read Our Latest Report on WALD
Waldencast Stock Down 2.2 %
The stock has a fifty day simple moving average of $6.75 and a 200 day simple moving average of $8.41.
Hedge Funds Weigh In On Waldencast
A number of institutional investors and hedge funds have recently modified their holdings of the company. California State Teachers Retirement System boosted its stake in shares of Waldencast by 19.4% in the 3rd quarter. California State Teachers Retirement System now owns 7,958 shares of the company's stock worth $75,000 after buying an additional 1,291 shares during the last quarter. Amalgamated Bank boosted its stake in shares of Waldencast by 68.1% in the 3rd quarter. Amalgamated Bank now owns 3,277 shares of the company's stock worth $31,000 after buying an additional 1,328 shares during the last quarter. UBS Group AG boosted its stake in shares of Waldencast by 295.8% in the 1st quarter. UBS Group AG now owns 3,297 shares of the company's stock worth $33,000 after buying an additional 2,464 shares during the last quarter. Goldman Sachs Group Inc. boosted its stake in shares of Waldencast by 12.0% in the 4th quarter. Goldman Sachs Group Inc. now owns 26,009 shares of the company's stock worth $285,000 after buying an additional 2,793 shares during the last quarter. Finally, Legal & General Group Plc purchased a new position in shares of Waldencast in the 3rd quarter worth $28,000. 41.97% of the stock is currently owned by hedge funds and other institutional investors.
Waldencast Company Profile
(
Get Free Report)
Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.
See Also
Before you consider Waldencast, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waldencast wasn't on the list.
While Waldencast currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
